Trials / Completed
CompletedNCT06009094
Safety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients with Mild to Moderate Atopic Dermatitis
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
This study is a single center, randomized, double-blind, Vehicle controlled,, single and multiple dose clinical study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | VC005 | VC005 group with Local topical application |
| DRUG | VC005 Placebo | VC005 Placebo group with Local topical application |
Timeline
- Start date
- 2023-07-27
- Primary completion
- 2024-05-23
- Completion
- 2024-05-23
- First posted
- 2023-08-24
- Last updated
- 2024-12-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06009094. Inclusion in this directory is not an endorsement.